147 related articles for article (PubMed ID: 36975468)
21. Infratentorial meningioma in an 8-year-old child as first sign of neurofibromatosis type 2.
Stettner GM; Rostasy KM; Ludwig HC; Merkler D; Fahsold R; Gärtner J
Neuropediatrics; 2007 Feb; 38(1):29-31. PubMed ID: 17607601
[TBL] [Abstract][Full Text] [Related]
22. Allelic losses in neurofibromatosis 2-associated meningiomas.
Lamszus K; Vahldiek F; Mautner VF; Schichor C; Tonn J; Stavrou D; Fillbrandt R; Westphal M; Kluwe L
J Neuropathol Exp Neurol; 2000 Jun; 59(6):504-12. PubMed ID: 10850863
[TBL] [Abstract][Full Text] [Related]
23. YAP1-MAML2 fusion in a pediatric NF2-wildtype intraparenchymal brainstem schwannoma.
Karajannis MA; Li BK; Souweidane MM; Liechty B; Yao J; Benhamida JK; Bale TA; Rosenblum MK
Acta Neuropathol Commun; 2022 Aug; 10(1):117. PubMed ID: 35986430
[TBL] [Abstract][Full Text] [Related]
24. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
[TBL] [Abstract][Full Text] [Related]
25. NF2-mutated Renal Carcinomas Have Common Morphologic Features Which Overlap With Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma: A Comprehensive Study of 14 Cases.
Paintal A; Tjota MY; Wang P; Fitzpatrick C; Wanjari P; Stadler WM; Gallan AJ; Segal J; Antic T
Am J Surg Pathol; 2022 May; 46(5):617-627. PubMed ID: 35034039
[TBL] [Abstract][Full Text] [Related]
26. [Molecular Biological Background of Neurofibromatosis Type 2].
Miyawaki S; Teranishi Y; Saito N
No Shinkei Geka; 2022 May; 50(3):572-577. PubMed ID: 35670170
[TBL] [Abstract][Full Text] [Related]
27. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas.
Antinheimo J; Sankila R; Carpén O; Pukkala E; Sainio M; Jääskeläinen J
Neurology; 2000 Jan; 54(1):71-6. PubMed ID: 10636128
[TBL] [Abstract][Full Text] [Related]
28. [Primary ectopic intraosseous meningioma associated with multiple meningioma in a patient with central neurofibromatosis].
Poptodorov G; Gabrovski S; Kamenova M; Nacheva M; Iordanov I; Shirov T; Petkov R; Dŭbov D
Khirurgiia (Sofiia); 2006; (4-5):64-7. PubMed ID: 18843923
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of MicroRNA Expression Depending on the Presence or Absence of Meningioma in Patients with Neurofibromatosis Type 2: A Secondary Analysis.
Imura T; Mitsuhara T; Horie N
Neurol Med Chir (Tokyo); 2024 Mar; 64(3):116-122. PubMed ID: 38267057
[TBL] [Abstract][Full Text] [Related]
30. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.
Lekanne Deprez RH; Bianchi AB; Groen NA; Seizinger BR; Hagemeijer A; van Drunen E; Bootsma D; Koper JW; Avezaat CJ; Kley N
Am J Hum Genet; 1994 Jun; 54(6):1022-9. PubMed ID: 7911002
[TBL] [Abstract][Full Text] [Related]
31. Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas.
Christiaans I; Kenter SB; Brink HC; van Os TA; Baas F; van den Munckhof P; Kidd AM; Hulsebos TJ
J Med Genet; 2011 Feb; 48(2):93-7. PubMed ID: 20930055
[TBL] [Abstract][Full Text] [Related]
32. Somatic Mosaicism of NF2 Gene Mutation with Constitutional NF1 Gene Mutation in Neurofibromatosis Type 2: a Case Report.
Yoo SJ; Hwang YS
Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180429
[TBL] [Abstract][Full Text] [Related]
33. The role and regulatory mechanism of IL-1β on the methylation of the NF2 gene in benign meningiomas and leptomeninges.
Wang B; Cui Z; Zhong Z; Sun Y; Yang GY; Sun Q; Bian L
Mol Carcinog; 2016 Dec; 55(12):2268-2277. PubMed ID: 26840621
[TBL] [Abstract][Full Text] [Related]
34. Renal cell carcinoma, unclassified with medullary phenotype: poorly differentiated adenocarcinomas overlapping with renal medullary carcinoma.
Sirohi D; Smith SC; Ohe C; Colombo P; Divatia M; Dragoescu E; Rao P; Hirsch MS; Chen YB; Mehra R; Amin MB
Hum Pathol; 2017 Sep; 67():134-145. PubMed ID: 28716439
[TBL] [Abstract][Full Text] [Related]
35. Ring chromosome 22 and neurofibromatosis type II: proof of two-hit model for the loss of the NF2 gene in the development of meningioma.
Zirn B; Arning L; Bartels I; Shoukier M; Hoffjan S; Neubauer B; Hahn A
Clin Genet; 2012 Jan; 81(1):82-7. PubMed ID: 21175598
[TBL] [Abstract][Full Text] [Related]
36. Neurofibromatosis type 2 and related disorders.
Halliday D; Parry A; Evans DG
Curr Opin Oncol; 2019 Nov; 31(6):562-567. PubMed ID: 31425178
[TBL] [Abstract][Full Text] [Related]
37. Molecular alterations in the neurofibromatosis type 2 gene and its protein rarely occurring in meningothelial meningiomas.
Evans JJ; Jeun SS; Lee JH; Harwalkar JA; Shoshan Y; Cowell JK; Golubic M
J Neurosurg; 2001 Jan; 94(1):111-7. PubMed ID: 11147878
[TBL] [Abstract][Full Text] [Related]
38. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
Hadfield KD; Smith MJ; Urquhart JE; Wallace AJ; Bowers NL; King AT; Rutherford SA; Trump D; Newman WG; Evans DG
Oncogene; 2010 Nov; 29(47):6216-21. PubMed ID: 20729918
[TBL] [Abstract][Full Text] [Related]
39. Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma.
Bhattacharyya S; Oblinger JL; Beauchamp RL; Yin Z; Erdin S; Koundinya P; Ware AD; Ferrer M; Jordan JT; Plotkin SR; Xu L; Chang LS; Ramesh V
Neuro Oncol; 2023 Sep; 25(9):1617-1630. PubMed ID: 36806881
[TBL] [Abstract][Full Text] [Related]
40. Loss of chromosome 22 and absence of NF2 gene mutation in a case of multiple meningiomas.
Lomas J; Bello MJ; Alonso ME; Gonzalez-Gomez P; Arjona D; Kusak ME; de Campos JM; Sarasa JL; Rey JA
Hum Pathol; 2002 Mar; 33(3):375-8. PubMed ID: 11979381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
